当前位置: X-MOL 学术J. Hepatol. › 论文详情
IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis
Journal of Hepatology ( IF 18.946 ) Pub Date : 2020-01-15 , DOI: 10.1016/j.jhep.2019.12.017
Florent Artru; Mohamed Bou Saleh; François Maggiotto; Guillaume Lassailly; Massih Ningarhari; Julie Demaret; Line-Carolle Ntandja-Wandji; Jean-Paul Pais de Barros; Julien Labreuche; Elodie Drumez; Doumet Georges Helou; Sébastien Dharancy; Emilie Gantier; Axel Périanin; Sylvie Chollet-Martin; Ramon Bataller; Philippe Mathurin; Laurent Dubuquoy; Alexandre Louvet

Background and aims Severe alcoholic hepatitis (SAH) is associated with a high risk of infection. The interleukin-33 (IL33)/ST2 pathway is involved in sepsis control but data in alcohol-related liver disease (ALD) are lacking. We aimed to characterize the role of IL-33/ST2 in the neutrophils (PMNs) of patients with ALD and SAH. Methods Serum and circulating neutrophils were collected from patients with SAH, alcoholic cirrhosis (Cirrh) and healthy controls (Ctrl). We quantified the IL-33/ST2 pathway and CXCR2 at baseline and after exposure to IL-33. We also determined the migration capacity of PMN. Results The decoy receptor of IL-33 (sST2) was increased in SAH vs. Cirrh and Ctrl, demonstrating the defect in this pathway during ALD. The sST2 level was associated with response to treatment, 2-month survival, infection-free survival and probability of infection in SAH. Endotoxemia was weakly correlated with sST2. GRK2, a negative regulator of CXCR2, was overexpressed in SAH and Cirrh PMNs and was decreased by IL-33. CXCR2 levels on PMNs were lower in SAH vs. Cirrh and Ctrl. Treatment with IL-33 partially restored CXCR2 expression in SAH and Cirrh. PMN migration upon IL-8 was lower in SAH and Cirrh vs. Ctrl. Treatment with IL-33 partially restored migration in SAH and Cirrh. Interestingly, the migration capacity of PMNs and the response to IL-33 were enhanced in responders to corticosteroids (Lille<0.45) compared to non-responders. Conclusion The IL33/ST2 pathway is defective in SAH and predicts outcome. This defect is associated with decreased CXCR2 expression on the surface of PMNs and lower migration capacity, which can be corrected by IL-33, especially in patients responding to steroids. These results suggest a therapeutic potential in SAH and its infectious complications.
更新日期:2020-01-15

 

全部期刊列表>>
化学/材料学中国作者研究精选
Springer Nature 2019高下载量文章和章节
ACS材料视界
自然科研论文编辑服务
中南大学国家杰青杨华明
剑桥大学-
中国科学院大学化学科学学院
材料化学和生物传感方向博士后招聘
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug